ANFOE 10000 IU 10000

About

ANFOE 10000 IU is a higher-dose formulation of recombinant human erythropoietin, designed to stimulate the production of red blood cells in individuals suffering from anemia. This medication is crucial for patients with conditions such as chronic kidney disease, where the body's natural erythropoietin production is insufficient, or in those undergoing chemotherapy, which can suppress bone marrow activity.

By increasing the red blood cell count, ANFOE 10000 IU helps to alleviate the debilitating symptoms of anemia, such as severe fatigue, weakness, and shortness of breath, thereby improving patient well-being and reducing the necessity for frequent blood transfusions. Close monitoring of hematological parameters and iron stores is essential during treatment.

Uses

• Severe anemia associated with chronic kidney disease
• Management of chemotherapy-induced anemia
• Treatment of anemia in certain myelodysplastic syndromes
• Reduction of allogeneic blood transfusion in high-risk surgical patients

Directions For Use

Administer subcutaneously or intravenously as directed by a healthcare professional. Do not shake the vial vigorously.

Benefits

• Significantly increases red blood cell levels
• Minimizes the need for blood transfusions
• Alleviates severe fatigue and weakness
• Enhances overall physical endurance
• Supports vital organ oxygenation
• Improves patient quality of life

Side Effects

• Hypertension (high blood pressure)
• Headache
• Thrombosis (blood clot formation)
• Injection site reactions
• Nausea and vomiting
• Fever
• Seizures
• Allergic reactions
• Flu-like symptoms
• Hyperkalemia
• Pure red cell aplasia (rare)
• Rash

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol intake can exacerbate anemia and impact overall health.
• Pregnancy - Use only if the potential benefits justify the potential risks to the fetus. Consult your physician before use.
• Breastfeeding - It is not known whether this medication is excreted in human milk. Exercise caution and seek medical advice.
• Liver - Use with caution in patients with hepatic impairment. No specific dose adjustments are typically needed, but monitor patient status.
• Kidney - Commonly used in chronic kidney disease. Close monitoring of blood pressure and hemoglobin levels is crucial.
• Lung - Generally safe, but vigilance for thromboembolic events is advised, particularly in patients with pre-existing cardiopulmonary conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.